Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

230
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
230
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

605
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
605
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

366
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
366
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

405
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
405
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

398
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
398
Drug Therapy01:28

Drug Therapy

450
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
450

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Infertility costs and associated factors in childhood cancer survivors: the role of radiotherapy.

Journal of cancer survivorship : research and practice·2026
Same author

First implementation of a collaborative care model for common mental disorders in primary care in France: fidelity of care manager intervention matters.

BMC health services research·2026
Same author

Total cervical occlusion: A solution after cervico-isthmic cerclage failure.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Same author

Magnetic Field-Responsive Smart bioMOF Composites Based on Bi(III)-Ellagate SU-101.

ACS applied materials & interfaces·2026
Same author

Developing a utility value set for the Alcohol Quality of Life Scale-Brief (AQoLS-Brief) using a discrete choice experiment.

Health and quality of life outcomes·2026
Same author

Changes in compliance with cardiovascular medication after a breast cancer diagnosis: a latent class trajectory analysis using French nationwide data.

Breast cancer research and treatment·2026

Related Experiment Video

Updated: May 5, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.0K

How and Why Do Multimorbid Patients Decide to Follow Their Multiple Medication Prescriptions? Looking Beyond the

Juliette Artignan1,2, Kevin Diter3, Pascal Clerc4,5

  • 1Primary Care and Prevention Team, Centre for Research in Epidemiology and Population Health (Inserm U1018), Villejuif, France.

Qualitative Health Research
|March 28, 2025
PubMed
Summary
This summary is machine-generated.

Multimorbid patients manage multiple medications differently, either deferring to doctors or actively engaging in decision-making. These adherence styles are linked to socioeconomic status, highlighting the need for coordinated care and patient communication.

Keywords:
chronic illnessmedication adherencemultimorbiditypatient decision-makingpolypharmacysocioeconomic status

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K

Related Experiment Videos

Last Updated: May 5, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.0K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K

Area of Science:

  • Pharmacology
  • Health Services Research
  • Sociology

Background:

  • Optimizing medication for multimorbid patients is crucial for adherence, safety, and cost-effectiveness.
  • Patient adherence to complex medication regimens remains poorly understood.
  • Multimorbidity necessitates careful management of multiple prescriptions.

Purpose of the Study:

  • To describe how patients account for adherence and non-adherence to multiple medications.
  • To explore the links between patients' adherence strategies and their socioeconomic status.
  • To understand patient decision-making processes in managing multiple prescriptions.

Main Methods:

  • Twenty semi-structured interviews with patients aged 47-82 with cardiovascular disease and chronic conditions.
  • Analysis using reflexive thematic analysis of transcribed interviews.
  • Application of Hirschman's theory of voice, exit, and loyalty to interpret findings.

Main Results:

  • Patients expressed shared concerns regarding multiple medication use and medical uncertainty from conflicting instructions.
  • Two distinct adherence styles emerged: deferring to physicians versus actively steering decision-making.
  • These styles correlated with differences in patient-physician engagement, side effect management, and prescription evaluation, and were linked to socioeconomic status.

Conclusions:

  • Patient adherence strategies vary significantly and are influenced by socioeconomic factors.
  • Coordinated care is essential to minimize prescription ambiguities for patients with multimorbidity.
  • Empowering patients with multimorbidity to voice concerns is vital for effective medication management.